Awarded TED · Source · Language: Deutsch

Germany · Medical equipment, pharmaceuticals and personal care products

Official title · Deutsch

Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu den Arzneimitteln Nuwiq (B02BD02), Octanate (B02BD02), Octanine F (B02BD04) und Wilate (B02BD06) bei Hämophilie

AOK Sachsen - Anhalt · Germany

View notices under this name

Official summary · Deutsch

What is being procured?

Die AOK Sachsen-Anhalt hat zur Behandlung der Hämophilie mit dem Hersteller der Arzneimittel Nuwiq (B02BD02), Octanate (B02BD02), Octanine F (B02BD04) und Wilate B02BD06) zum 01.09.2026 einen Vertrag gem. § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V abgeschlossen.

Deadline Not announced
Estimated valueNot announced
PublishedSep 3, 2026
Open official notice ↗

Notice history

Procurement timeline

Follow the main stages and updates linked to this procurement procedure.

No other related notice has been identified yet.

  1. Result notice Current notice

    · TED 608473-2026

    Open official notice ↗

Data is restructured for easier reading. The official notice and procurement documents always prevail.

Source and reliability

TED · 608473-2026. Checked on Sep 4, 2026, 9:05 AM.

Data is restructured for easier reading. The official notice and procurement documents always prevail.

Report an error by email